| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
109.12(B) |
| Last
Volume: |
5,365,633 |
Avg
Vol: |
8,385,378 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
1,002,990 |
2,126,174 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$61,125,774 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
44 |
80 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gilbert James |
EVP, Strategy & Business Dev |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,314 |
68,707 |
|
- |
|
| Pedersen John B. |
Pres,Uro & Womens Health |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$3,931 |
D/D |
(504) |
1,441 |
|
- |
|
| Pedersen John B. |
Pres,Uro & Womens Health |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,326 |
1,945 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$9,142 |
D/D |
(1,172) |
51,908 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
53,080 |
|
- |
|
| Phalen Michael P. |
SVP & President, Endoscopy |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$13,650 |
D/D |
(1,750) |
24,696 |
|
- |
|
| Phalen Michael P. |
SVP & President, Endoscopy |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,699 |
26,446 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$7,465 |
D/D |
(957) |
61,540 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
62,497 |
|
- |
|
| Colen Fred |
EVP & Chief Technology Officer |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$7,683 |
D/D |
(985) |
64,842 |
|
- |
|
| Colen Fred |
EVP & Chief Technology Officer |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
65,827 |
|
- |
|
| Capello Jeffrey D |
SVP, Chief Accounting Officer |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$8,923 |
D/D |
(1,144) |
21,882 |
|
- |
|
| Capello Jeffrey D |
SVP, Chief Accounting Officer |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
23,026 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$4,025 |
D/D |
(516) |
33,059 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,326 |
33,575 |
|
- |
|
| Leno Sam R |
CFO & EVP Finance & IS |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,024 |
233,488 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$7,465 |
D/D |
(957) |
44,421 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
45,378 |
|
- |
|
| Burns Brian R |
SVP - Global Quality |
• – – |
2010-02-24 |
4 |
D |
$7.80 |
$8,954 |
D/D |
(1,148) |
39,433 |
|
- |
|
| Burns Brian R |
SVP - Global Quality |
• – – |
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,615 |
40,581 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-16 |
4 |
D |
$7.41 |
$8,418 |
D/D |
(1,136) |
32,249 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,920 |
33,385 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2010-02-16 |
4 |
D |
$7.41 |
$5,202 |
D/D |
(702) |
22,876 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2010-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,635 |
23,578 |
|
- |
|
| Phalen Michael P. |
SVP & President, Endoscopy |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$9,186 |
D/D |
(1,243) |
21,343 |
|
- |
|
1824 Records found
|
|
Page 44 of 73 |
|
|
0.12 (0.16%) 
